1. Medtech Insight

Industry Groups Push CMS To Pay For Algorithms In Multi-Analyte Tests

The agency’s proposal not to separately pay for the algorithmic analysis that forms the basis of many multi-analyte molecular diagnostic tests misconstrues the nature of the tests, industry groups argue. They call for a final determination by CMS that more truly reflects the value of these assays.

CMS’ proposal not to establish payments for newly created codes for multi-analyte assays that rely on algorithmic analysis is attracting a strong rebuke from diagnostic industry and lab stakeholders.

AdvaMedDx, the American Clinical Laboratory Association (ACLA) and Biotechnology Industry Organization (BIO) each pressed CMS in recent comments to withdraw its proposal and issue final payment decisions that considers the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight